(Q35897492)

11 August 2017

Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers (English)

1 reference

11 August 2017

1 reference

1 reference

Israel D

1

1 reference

11 August 2017

Gillum JG

2

1 reference

11 August 2017

Turik M

3

1 reference

11 August 2017

Harvey K

4

1 reference

11 August 2017

Ford J

5

1 reference

11 August 2017

Dalton H

6

1 reference

11 August 2017

Towle M

7

1 reference

11 August 2017

Echols R

8

1 reference

11 August 2017

Heller AH

9

1 reference

11 August 2017

Polk R

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

11 August 2017

7

1 reference

Antimicrobial Agents and Chemotherapy

inferred from page(s)

published in

1 reference

11 August 2017

37

1 reference

11 August 2017

10

1 reference

11 August 2017

2193-2199

1 reference

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Analysis of a new method for assessing activity of combinations of antimicrobials: area under the bactericidal activity curve

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Comparative pharmacokinetics of intravenous ofloxacin and ciprofloxacin.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Correlation of predicted serum bactericidal activities and values measured in volunteers.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

27 July 2018

Serum bactericidal test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Serum inhibitory and bactericidal activity of ciprofloxacin following intravenous administration.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Comparative pharmacokinetics of ofloxacin and ciprofloxacin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Fluoroquinolone antimicrobial agents

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Infectious Complications with Respiratory Pathogens despite Ciprofloxacin Therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin alone and in combination in healthy elderly volunteers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Mathematical Examination of Dual Individualization Principles (I): Relationships between AUC above MIC and Area under the Inhibitory Curve for Cefmenoxime, Ciprofloxacin, and Tobramycin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=192249

Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration

24 September 2018

1 reference

12 December 2020

Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule

1 reference

12 December 2020

Emerging resistance to fluoroquinolones in staphylococci: an alert

1 reference

12 December 2020

Analysis of serum bactericidal activity in endocarditis, osteomyelitis, and other bacterial infections

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.37.10.2193

1 reference

11 August 2017

1 reference

11 August 2017

1 reference